Terms: = Kidney tumors AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Prognosis
4627 results:
1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract] [Full Text] [Related]
4. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
[TBL] [Abstract] [Full Text] [Related]
5. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract] [Full Text] [Related]
7. Cardiac and Intramuscular Metastases Following Nephroureterectomy for Metachronous Urothelial Carcinoma.
Chan HY; Chan WY; Wong Su Lin J
Am J Case Rep; 2024 Apr; 25():e942864. PubMed ID: 38650318
[TBL] [Abstract] [Full Text] [Related]
8. Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification.
Lu Z; Pan Y; Wang S; Wu J; Miao C; Wang Z
Eur J Med Res; 2024 Apr; 29(1):236. PubMed ID: 38622715
[TBL] [Abstract] [Full Text] [Related]
9. zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma.
Zhang X; Hou J; Zhou G; Wang H; Wu Z
J Cancer Res Clin Oncol; 2024 Apr; 150(4):194. PubMed ID: 38619631
[TBL] [Abstract] [Full Text] [Related]
10. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
[TBL] [Abstract] [Full Text] [Related]
11. Association between PD-L1 Expression and the prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma.
Chrabańska M; Szweda-Gandor N; Rynkiewicz M; Hraboš D; Drozdzowska B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612724
[TBL] [Abstract] [Full Text] [Related]
12. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
13. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody.
Ouchida T; Li G; Suzuki H; Yanaka M; Nakamura T; Handa S; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):53-58. PubMed ID: 38593441
[TBL] [Abstract] [Full Text] [Related]
14. Vaporization phosphorization-mediated synthesis of phosphorus-doped TiO
Song Z; Guan C; Li T; Li C; Zhang N; Liu K; Yang C; Zhu Y; Xu Y
J Mater Chem B; 2024 Apr; 12(16):4039-4052. PubMed ID: 38591157
[TBL] [Abstract] [Full Text] [Related]
15. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
Xu J; Bai J; Pan H; Zhou Z
Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
[TBL] [Abstract] [Full Text] [Related]
16. Heterotopic bone formation in a case of clear cell renal cell carcinoma: A case report.
Bavikar R; Patel P; Verma A; Ingale Y; Randive R
J Cancer Res Ther; 2024 Jan; 20(1):482-484. PubMed ID: 38554371
[TBL] [Abstract] [Full Text] [Related]
17. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
[TBL] [Abstract] [Full Text] [Related]
18. Recurrence of locally invasive retroperitoneal dedifferentiated liposarcoma shortly after surgery: A case report and literature review.
Hu X; Han B; Yang Q; Li Q; Xiao D; Xu X
Medicine (Baltimore); 2024 Mar; 103(13):e37604. PubMed ID: 38552050
[TBL] [Abstract] [Full Text] [Related]
19. Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.
Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J
Cancer Med; 2024 Apr; 13(7):e7113. PubMed ID: 38545824
[TBL] [Abstract] [Full Text] [Related]
20. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
[TBL] [Abstract] [Full Text] [Related]
[Next]
